Wenhua Huang

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

Correction: STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 07, 2024

PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.

PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 30, 2024

STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 03, 2024

MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5.

MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 25, 2024

Fatigue Performance Analysis of Welded T-Joints in Orthotropic Steel Bridge Decks with Ultrasonic Impact Treatment.

Fatigue Performance Analysis of Welded T-Joints in Orthotropic Steel Bridge Decks with Ultrasonic Impact Treatment.

Journal: Materials (Basel, Switzerland)

Published: August 15, 2023

Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.

Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.

Journal: Clinical and translational medicine

Published: June 14, 2023

HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway.

HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway.

Journal: Cell death & disease

Published: April 29, 2022

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 20, 2019

Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.

Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.

Journal: Cell death & disease

Published: August 14, 2016

Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression.

Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression.

Journal: Oncotarget

Published: January 26, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026